I‐Ling Lin
Impact in
- Molecular Medicine top 5%
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Ubiquitin and proteasome pathways 4
- Cancer therapeutics and mechanisms 3
-
- Hydrogels: synthesis, properties, applications 6
- Co-authors
- Chien‐Chih Chiu (14 shared papers)Sheng‐Kai Hsu (8 shared papers)Kai‐Chun Cheng (4 shared papers)Yih‐Fung Chen (2 shared papers)Yen‐Ni Teng (2 shared papers)Chia‐Yang Li (2 shared papers)Chia‐Hung Yen (1 shared paper)Yi‐Hsiung Lin (1 shared paper)
- Journals
- International Journal of Molecular Sciences (5 papers)Cancer Cell International (4 papers)Gels (2 papers)International Journal of Molecular Medicine (2 papers)Clinical Biochemistry (2 papers)
- Partner nations
- TaiwanUnited StatesMacao
In The Last Decade
I‐Ling Lin
57 papers receiving 1.5k citations
I‐Ling Lin's Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Medicine 79
- Cancer Research 194
- Molecular Biology 632
- Hepatology 60
- Immunology 146
Countries citing papers authored by I‐Ling Lin
This map shows the geographic impact of I‐Ling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Ling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Ling Lin more than expected).
Fields of papers citing papers by I‐Ling Lin
This network shows the impact of papers produced by I‐Ling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Ling Lin. The network helps show where I‐Ling Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside I‐Ling Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment Hit paper breakdown → | 2021 | 373 |
| 2 | 2014 | 100 | |
| 3 | 2019 | 96 | |
| 4 | 2020 | 88 | |
| 5 | 2008 | 85 | |
| 6 | 2013 | 56 | |
| 7 | 2019 | 55 | |
| 8 | 2017 | 47 | |
| 9 | 2016 | 47 | |
| 10 | 2020 | 43 | |
| 11 | 2010 | 33 | |
| 12 | 2021 | 33 | |
| 13 | 2013 | 28 | |
| 14 | 2019 | 26 | |
| 15 | 2003 | 25 | |
| 16 | 2003 | 23 | |
| 17 | 2013 | 21 | |
| 18 | 2019 | 20 | |
| 19 | 2023 | 19 | |
| 20 | 2009 | 15 |
About I‐Ling Lin
I‐Ling Lin is a scholar working on Molecular Biology, Molecular Medicine, Pharmaceutical Science, Epidemiology and Oncology, having authored 58 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hydrogels: synthesis, properties, applications (6 papers), Advanced Drug Delivery Systems (6 papers), Hepatitis C virus research (5 papers), Ubiquitin and proteasome pathways (4 papers), Autophagy in Disease and Therapy (4 papers), Advancements in Transdermal Drug Delivery (3 papers), Cancer therapeutics and mechanisms (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Molecular Medicine (79 citations), Cancer Research (194 citations), Molecular Biology (632 citations), Hepatology (60 citations) and Immunology (146 citations). I‐Ling Lin has collaborated with scholars based in Taiwan, United States and Macao. Frequent co-authors include Chien‐Chih Chiu, Sheng‐Kai Hsu, Kai‐Chun Cheng, Yih‐Fung Chen, Yen‐Ni Teng, Chia‐Yang Li, Chia‐Hung Yen, Yi‐Hsiung Lin, Wen‐Tsan Chang and Chon‐Kit Chou. Their work appears in journals such as International Journal of Molecular Sciences, Cancer Cell International, Gels, International Journal of Molecular Medicine and Clinical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.